CNR Institutional Research Information System

SALVARESE, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.469
NA - Nord America 850
EU - Europa 409
SA - Sud America 260
AF - Africa 31
OC - Oceania 5
Totale 3.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 802
SG - Singapore 585
CN - Cina 399
BR - Brasile 199
VN - Vietnam 150
HK - Hong Kong 129
NL - Olanda 92
FR - Francia 86
IT - Italia 67
KR - Corea 64
GB - Regno Unito 43
JP - Giappone 33
BD - Bangladesh 26
CA - Canada 26
AR - Argentina 25
DE - Germania 24
IN - India 20
FI - Finlandia 16
PL - Polonia 15
MX - Messico 13
EC - Ecuador 10
ID - Indonesia 10
IL - Israele 9
ZA - Sudafrica 9
BE - Belgio 8
CO - Colombia 8
ES - Italia 7
IQ - Iraq 7
RU - Federazione Russa 7
TR - Turchia 7
BG - Bulgaria 6
VE - Venezuela 6
CH - Svizzera 4
EG - Egitto 4
ET - Etiopia 4
KG - Kirghizistan 4
PE - Perù 4
PK - Pakistan 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AU - Australia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IE - Irlanda 3
PH - Filippine 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
CL - Cile 2
DZ - Algeria 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UA - Ucraina 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 3.024
Salva come PNG Salva come JPEG
Città #
Singapore 344
Santa Clara 233
San Jose 138
Hefei 127
Hong Kong 126
Beijing 79
Seoul 64
Lauterbourg 58
Ho Chi Minh City 53
Ashburn 48
Dallas 41
Los Angeles 38
Hanoi 31
Tokyo 25
Guangzhou 22
New York 22
São Paulo 19
Frankfurt am Main 15
Buffalo 12
Warsaw 12
Toronto 11
Brasília 9
Haiphong 9
Hải Dương 9
Bengaluru 8
Biên Hòa 7
Brussels 7
Minamishinagawa 7
Recife 7
Rio de Janeiro 7
Da Nang 6
Lappeenranta 6
London 6
Chicago 5
City of London 5
Goiânia 5
Mexico City 5
Montreal 5
Ottawa 5
Poplar 5
Turku 5
Belém 4
Brooklyn 4
Cairo 4
Council Bluffs 4
Düsseldorf 4
Elk Grove Village 4
Guarulhos 4
Helsinki 4
Johannesburg 4
Milan 4
Newark 4
Phoenix 4
Quận Năm 4
Sofia 4
Southwark 4
Addis Ababa 3
Amsterdam 3
Ankara 3
Athens 3
Atlanta 3
Baghdad 3
Belo Horizonte 3
Bishkek 3
Boardman 3
Boston 3
Bucharest 3
Buenos Aires 3
Curitiba 3
Denver 3
Dublin 3
Fortaleza 3
Guayaquil 3
Lima 3
Lucca 3
Manaus 3
Munich 3
Orem 3
Padova 3
Prague 3
Quito 3
Quận Bình Thạnh 3
Roubaix 3
Shanghai 3
Tashkent 3
Vienna 3
Zurich 3
Acalanes Ridge 2
Annapolis 2
Araranguá 2
Asunción 2
Auckland 2
Bogotá 2
Bologna 2
Bratislava 2
Bắc Giang 2
Campo Largo 2
Camponogara 2
Campos dos Goytacazes 2
Cao Lanh 2
Totale 1.825
Salva come PNG Salva come JPEG
Nome #
Copper(II) and copper(I) complexes with a bidentate hydrazinic dithiocarbazate: synthesis and crystal structures 96
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations 93
Assessment of the best N3- donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ) 79
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 75
A Review on the Current State and Future Perspectives of [99mTc]Tc-Housed PSMA-i in Prostate Cancer 73
IMPACT OF DIFFERENT [Tc(N)PNP]-FRAMEWORKS ON THE PHARMACOKINETICS OF THE SMALL RGDFK PEPTIDE 67
Evaluation of [99mTc]Tc(CO)3+ moiety labeled ?-melanocyte stimulating hormone derived peptide conjugatesfor potential melanoma imaging 66
Improved synthesis on solid phase of dithiocarbamic cRGD-derivative and Tc-99m-radiolabelling 62
Selective Detection of alfa_v beta_3 Integrin Receptors Using [99mTc(N)PNP]-labelled RGDechi Peptides 57
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta (3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. 56
[Tc-99m(N)PNP]-moiety: a suitable scaffold for the developmant of radiolabeled probes for SPECT of multidrug resistance. In vitro study 56
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 55
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 54
SITE-SPECIFIC [99mTc][Tc(CO)3(OH2)3]-LABELED scFvD2B-HysTag FOR SPECT IMAGING OF PSMA IN PROSTATE CANCER 53
Synthesis and biological evaluation of new [Tc-99m(III)( PS)(2)(L)] mixed-ligand compounds (PS= phosphino-thiolate; L=dithiocarbamate), useful in design and development of Tc(III)radiopharmaceuticals 52
Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 51
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies. 51
Tc-III-based mixed complexes for the design and the development of new SPECT tracers 51
[ 99m Tc][Tc(N)(DASD)(PNP n)] + (DASD = 1,4-Dioxa-8-azaspiro[4,5]decandithiocarbamate, PNP n = Bisphosphinoamine) for Myocardial Imaging: Synthesis, Pharmacological and Pharmacokinetic Studies 51
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)(2)NR diphosphinoamine ligands 50
[99mTc][Tc(N)PNP]-tagging of the small RGDfK peptide: impact of different PNP structures on the labeling and pharmacokinetics of the radioconjugates 50
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635. 49
Synthesis and characterization of novel hexacoordinated, asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 49
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 48
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example. 47
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 47
Water-Soluble [Tc(N)(PNP)] Moiety for Room-Temperature 99mTc Labeling of Sensitive Target Vectors 47
Cu-64-labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies 46
Synthesis, Characterization, and Initial Biological Evaluation of [99mTc]Tc-Tricarbonyl-labeled DPA-?-MSH Peptide Derivatives for Potential Melanoma Imaging 46
Synthesis, characterization and in vitro cytotoxicity of gallium(iii)-dithiocarbamate complexes 46
Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer Cells 46
Synthesis and characterization of novel asymmetrical M(III) (M = Re, Tc-99g) complexes as models for the development of new potential tracers for SPECT imaging and radiotherapy 45
[Tc-99m(N)PNP]-scaffold for SPECT of multidrug resistance: Early in-vitro study 45
Reactivity of the [M(PS)2](+) Building Block (M = Re(III) and (99m)Tc(III); PS = Phosphinothiolate) toward Isopropylxanthate and Pyridine-2-thiolate. 45
Melanoma targeting with [(TcN)-Tc-99m(PNP3)]-labeled alpha-MSH peptide analogs: Preliminary studies 45
Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies 44
Chelating Systems for Tc-99m/Re-188 in the Development of Radiolabeled Peptide Pharmaceuticals 42
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy. 42
Synthesis and characterization of rhenium(III) complexes with pincer-like PNP(R) ligands 41
Water-soluble [Tc(N)(PNP)]-moiety for the room temperature labeling of sensitive molecules 41
, [188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 39
Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy 39
[188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 39
LC-MS and MALDI-TOF supported metabolism studies of the selective ?v?3 RGDechi peptide and of thecorresponding [99mTc(N)PNP]-tagged derivatives. 39
Synthesis and biological evaluation of [188Re(N)(CYS~)(PNP)]+/0 complexes as prototypes for the development of [188Re(N)(PNP)-based target vectors 38
Cu-64-dithiocarbamate compounds for theragnostic applications: Preliminary in-vitro studies 38
Synthesis, characterization and biological evaluation of [(188)Re(N)(cys similar to)(PNP)](+/0) mixed-ligand complexes as prototypes for the development of (188)Re(N)-based target-specific radiopharmaceuticals 37
A Bis(Thiosemicarbazone) bifunctional chelating agent for Nitrido-Tchnetium-99m and Copper 64-basedRadiopharmaceuticals 36
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study 36
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 35
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 34
New Tc-99m-radioimmunoconjugates for pancreatic carcinoma detection 34
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imagin and radiotherapy 34
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 31
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 31
Tc-99m(N)-DBODC(5) from cardiology to oncology: preliminary in vitro study. 29
Tc-99m(N)-DBODC(5) a new radiolabelled probe for SPECT imaging of Multidrug resistance. In vitro studies. 28
Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate, PNP = bisphosphinoamine). 28
[Tc-99m(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 28
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine 27
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635. 27
Site-specific derivatization of apomyoglobin with H2BTS-6ACA mediated by transglutaminase 26
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 25
Synthesis and biological evaluation of new [Tc(N)(R2PS)]-based mixed compounds as analogues of WAY 100635 25
[Re-188(N)(cys similar to)(PNP)](+/0) mixed ligand compounds as models for target specific agents 24
New [Tc-99m(N)(DTC)(PNP)](+) complexes as potential myocardial imaging agents. 24
Preliminary studies on the transglutaminase-mediated derivatizations of Apomyoglobin (apoMb) with H2ATSM-6ACA 23
Synthesis, Characterization, and Biological Evaluation of [188Re(N)(cys~)(PNP)]+/0 mixedligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals 23
Reactions of the tridentate and tetradentate amine ligands di-(2-picolyl)(N-ethyl)amine and 2,5-bis-(2-pyridylmethyl)-2,5 diazohexane with technetium nitrosyl complexes 10
Totale 3.046
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.877
article - articoli 5.278
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 166
Totale 15.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202434 0 0 0 0 0 0 0 0 0 0 33 1
2024/20251.211 14 4 97 32 206 70 43 101 43 106 267 228
2025/20261.801 92 150 175 263 341 70 234 88 79 142 67 100
Totale 3.046